CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a new class of immunosuppressive drugs that selectively inhibit the proliferation of T and B lymphocytes by targeting a specific protein, CTPS1. The goal is to create safer treatments for conditions like organ transplantation and autoimmune diseases.
The idea of the proposal is to prove the relevance of the development a novel class of immunosuppressive drugs with a better safety.
These agents will aim at selectively inhibit the proliferation of T (and B) lymphocytes by targeting a medically relevant target (named CTPS1) recently identified by Dr Latour in the team of Pr Fischer.
Proliferation of T lymphocytes is a normal component of the immune reaction toward an antigen, but in certain circumstances, the proliferation of activated T lympho…
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
